Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer.

Szucs, Thomas D; Szillat, Kevin P; Blozik, Eva

Szucs, Thomas D; Szillat, Kevin P; Blozik, Eva.

Afiliación

Szucs TD; University of Basel, Institute of Pharmaceutical Medicine (ECPM), Basel, Switzerland.
Szillat KP; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zürich, Switzerland.
Blozik E; Department of Health Sciences, Helsana Group, Zürich, Switzerland.

Pharmgenomics Pers Med ; 11: 67-69, 2018.

Article en En | MEDLINE | ID: mdl-29731658

Palabras clave

Switzerland; budget impact model; health insurance; oncology; pharmacogenetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Pharmgenomics Pers Med Año: 2018 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google